Clinical Trial Update: Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity [NA]

View source ↗

Summary

A clinical trial is evaluating glucagon-like peptide-1 receptor agonist therapy in combination with exercise training for obesity; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GLP-1 receptor agonist therapy (glucagon-like peptide-1 receptor agonist)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Obesity, Skeletal Muscle | NA | Status: RECRUITING